Literature DB >> 23270483

Energetic coupling between an oxidizable cysteine and the phosphorylatable N-terminus of human liver pyruvate kinase.

Todd Holyoak1, Bing Zhang, Junpeng Deng, Qingling Tang, Charulata B Prasannan, Aron W Fenton.   

Abstract

During our efforts to characterize the regulatory properties of human liver pyruvate kinase (L-PYK), we have noted that the affinity of the protein for phosphoenolpyruvate (PEP) becomes reduced several days after cell lysis. A 1.8 Å crystallographic structure of L-PYK with the S12D mimic of phosphorylation indicates that Cys436 is oxidized, the first potential insight into explaining the effect of "aging". Interestingly, the oxidation is only to sulfenic acid despite the crystal growth time period of 2 weeks. Mutagenesis confirms that the side chain of residue 436 is energetically coupled to PEP binding. Mass spectrometry confirms that the oxidation is present in solution and is not an artifact caused by X-ray exposure. Exposure of the L-PYK mutations to H₂O₂ also confirms that PEP affinity is sensitive to the nature of the side chain at position 436. A 1.95 Å structure of the C436M mutant of L-PYK, the only mutation at position 436 that has been shown to strengthen PEP affinity, revealed that the methionine substitution results in the ordering of several N-terminal residues that have not been ordered in previous structures. This result allowed speculation that oxidation of Cys436 and phosphorylation of the N-terminus at Ser12 may function through a similar mechanism, namely the interruption of an activating interaction between the nonphosphorylated N-terminus with the nonoxidized main body of the protein. Mutant cycles were used to provide evidence that mutations of Cys436 are energetically synergistic with N-terminal modifications, a result that is consistent with phosphorylation of the N-terminus and oxidation of Cys436 functioning through mechanisms with common features. Alanine-scanning mutagenesis was used to confirm that the newly ordered N-terminal residues were important to the regulation of enzyme function by the N-terminus of the enzyme (i.e., not an artifact caused by the introduced methionine substitution) and to further define which residues in the N-terminus are energetically coupled to PEP affinity. Collectively, these studies indicate energetic coupling (and potentially mechanistic similarities) between the oxidation of Cys436 and phosphorylation of Ser12 in the N-terminus of L-PYK.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23270483      PMCID: PMC3572911          DOI: 10.1021/bi301341r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  31 in total

1.  Evidence for long range allosteric interactions between the extracellular and cytoplasmic parts of bacteriorhodopsin from the mutant R82A and its second site revertant R82A/G231C.

Authors:  U Alexiev; R Mollaaghababa; H G Khorana; M P Heyn
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

Review 2.  A deliberate approach to screening for initial crystallization conditions of biological macromolecules.

Authors:  Joseph R Luft; Robert J Collins; Nancy A Fehrman; Angela M Lauricella; Christina K Veatch; George T DeTitta
Journal:  J Struct Biol       Date:  2003-04       Impact factor: 2.867

3.  An improved protocol for rapid freezing of protein samples for long-term storage.

Authors:  Junpeng Deng; Douglas R Davies; Goragot Wisedchaisri; Meiting Wu; Wim G J Hol; Christopher Mehlin
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2003-12-18

4.  Quantitative analysis and interpretation of allosteric behavior.

Authors:  Gregory D Reinhart
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

5.  Probing L-pyruvate kinase regulatory phosphorylation site by mutagenesis.

Authors:  Ilona Faustova; Mart Loog; Jaak Järv
Journal:  Protein J       Date:  2012-10       Impact factor: 2.371

6.  Proteolytic modification of pig and rat liver pyruvate kinase type L including phosphorylatable site.

Authors:  G Bergström; P Ekman; E Humble; L Engström
Journal:  Biochim Biophys Acta       Date:  1978-02-15

7.  Structure and function of human erythrocyte pyruvate kinase. Molecular basis of nonspherocytic hemolytic anemia.

Authors:  Giovanna Valentini; Laurent R Chiarelli; Riccardo Fortin; Manuela Dolzan; Alessandro Galizzi; Donald J Abraham; Changqing Wang; Paola Bianchi; Alberto Zanella; Andrea Mattevi
Journal:  J Biol Chem       Date:  2002-04-17       Impact factor: 5.157

Review 8.  The sulfinic acid switch in proteins.

Authors:  Claus Jacob; Andrea L Holme; Fiona H Fry
Journal:  Org Biomol Chem       Date:  2004-06-29       Impact factor: 3.876

9.  Distribution of pyruvate kinase type L and M2 in microdissected periportal and perivenous rat liver tissue with different dietary states.

Authors:  S Zierz; N Katz; K Jungermann
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1983-10

10.  Possible involvement of pyruvate kinase in acquisition of tolerance to hypoxic stress in glial cells.

Authors:  Takahiro Shimizu; Takashi Uehara; Yasuyuki Nomura
Journal:  J Neurochem       Date:  2004-10       Impact factor: 5.372

View more
  18 in total

1.  Whole-protein alanine-scanning mutagenesis of allostery: A large percentage of a protein can contribute to mechanism.

Authors:  Qingling Tang; Aron W Fenton
Journal:  Hum Mutat       Date:  2017-06-16       Impact factor: 4.878

2.  Chokepoints in Mechanical Coupling Associated with Allosteric Proteins: The Pyruvate Kinase Example.

Authors:  Lewis E Johnson; Bojana Ginovska; Aron W Fenton; Simone Raugei
Journal:  Biophys J       Date:  2019-04-02       Impact factor: 4.033

3.  RheoScale: A tool to aggregate and quantify experimentally determined substitution outcomes for multiple variants at individual protein positions.

Authors:  Abby M Hodges; Aron W Fenton; Larissa L Dougherty; Andrew C Overholt; Liskin Swint-Kruse
Journal:  Hum Mutat       Date:  2018-08-28       Impact factor: 4.878

4.  Distinguishing the interactions in the fructose 1,6-bisphosphate binding site of human liver pyruvate kinase that contribute to allostery.

Authors:  Arjun Ishwar; Qingling Tang; Aron W Fenton
Journal:  Biochemistry       Date:  2015-02-12       Impact factor: 3.162

5.  Changes in the allosteric site of human liver pyruvate kinase upon activator binding include the breakage of an intersubunit cation-π bond.

Authors:  Jeffrey S McFarlane; Trey A Ronnebaum; Kathleen M Meneely; Annemarie Chilton; Aron W Fenton; Audrey L Lamb
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-06-10       Impact factor: 1.056

6.  Benchmarking predictions of allostery in liver pyruvate kinase in CAGI4.

Authors:  Qifang Xu; Qingling Tang; Panagiotis Katsonis; Olivier Lichtarge; David Jones; Samuele Bovo; Giulia Babbi; Pier L Martelli; Rita Casadio; Gyu Rie Lee; Chaok Seok; Aron W Fenton; Roland L Dunbrack
Journal:  Hum Mutat       Date:  2017-05-02       Impact factor: 4.878

7.  Exploring the limits of the usefulness of mutagenesis in studies of allosteric mechanisms.

Authors:  Qingling Tang; Aileen Y Alontaga; Todd Holyoak; Aron W Fenton
Journal:  Hum Mutat       Date:  2017-05-23       Impact factor: 4.878

8.  Are all regions of folded proteins that undergo ligand-dependent order-disorder transitions targets for allosteric peptide mimetics?

Authors:  Aron W Fenton
Journal:  Biopolymers       Date:  2013-11       Impact factor: 2.505

Review 9.  The redox biochemistry of protein sulfenylation and sulfinylation.

Authors:  Mauro Lo Conte; Kate S Carroll
Journal:  J Biol Chem       Date:  2013-07-16       Impact factor: 5.157

10.  Distinct Hepatic PKA and CDK Signaling Pathways Control Activity-Independent Pyruvate Kinase Phosphorylation and Hepatic Glucose Production.

Authors:  Brandon M Gassaway; Rebecca L Cardone; Anil K Padyana; Max C Petersen; Evan T Judd; Sebastian Hayes; Shuilong Tong; Karl W Barber; Maria Apostolidi; Abudukadier Abulizi; Joshua B Sheetz; Hans R Aerni; Stefan Gross; Charles Kung; Varman T Samuel; Gerald I Shulman; Richard G Kibbey; Jesse Rinehart
Journal:  Cell Rep       Date:  2019-12-10       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.